Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome

Published:2021-09 Issue: Volume:15 Page:92-96
ISSN:2352-5126
Container-title:JAAD Case Reports
language:en
Short-container-title:JAAD Case Reports

Author:

Maredia Hasina,Cozzio Antonio,Dummer Reinhard,Ramelyte Egle,Kim Ellen J.,Rozati Sima

Funder

Takeda Pharmaceuticals U.S.A.

Novartis

Les Laboratories Pierre Fabre

Roche

Kyowa Hakko Kirin

Amgen

MedImmune

Bristol-Myers Squibb

Sanofi

Publisher

Elsevier BV

Subject

Dermatology

Reference15 articles.

1. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers;Jawed;J Am Acad Dermatol,2014

2. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome;Benton;Eur J Cancer,2013

3. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal;Agar;J Clin Oncol,2010

4. Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and development of a prognostic model;Scarisbrick;J Clin Oncol,2015

5. Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndrome;Danish;Leuk Lymphoma,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Is New in Cutaneous T Cell Lymphoma?;Current Oncology Reports;2023-10-24

2. Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma;Cells;2022-11-13

3. Multiple drugs;Reactions Weekly;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3